Does TAZEMETOSTAT HYDROBROMIDE Cause Hospitalisation? 24 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 24 reports of Hospitalisation have been filed in association with TAZEMETOSTAT HYDROBROMIDE (TAZVERIK). This represents 1.8% of all adverse event reports for TAZEMETOSTAT HYDROBROMIDE.
24
Reports of Hospitalisation with TAZEMETOSTAT HYDROBROMIDE
1.8%
of all TAZEMETOSTAT HYDROBROMIDE reports
5
Deaths
23
Hospitalizations
How Dangerous Is Hospitalisation From TAZEMETOSTAT HYDROBROMIDE?
Of the 24 reports, 5 (20.8%) resulted in death, 23 (95.8%) required hospitalization.
Is Hospitalisation Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TAZEMETOSTAT HYDROBROMIDE. However, 24 reports have been filed with the FAERS database.
What Other Side Effects Does TAZEMETOSTAT HYDROBROMIDE Cause?
Off label use (298)
Fatigue (292)
Disease progression (267)
Nausea (207)
Product dose omission issue (183)
Death (106)
Diarrhoea (100)
Decreased appetite (81)
Asthenia (75)
Vomiting (75)
What Other Drugs Cause Hospitalisation?
CLOZAPINE (12,144)
CINACALCET (6,997)
DARBEPOETIN ALFA (5,682)
MACITENTAN (3,414)
APIXABAN (3,315)
ADALIMUMAB (3,033)
DUPILUMAB (2,529)
LENALIDOMIDE (2,241)
DENOSUMAB (2,076)
PALIPERIDONE (2,066)
Which TAZEMETOSTAT HYDROBROMIDE Alternatives Have Lower Hospitalisation Risk?
TAZEMETOSTAT HYDROBROMIDE vs TAZOBACTAM
TAZEMETOSTAT HYDROBROMIDE vs TBO-FILGRASTIM
TAZEMETOSTAT HYDROBROMIDE vs TEBENTAFUSP-TEBN
TAZEMETOSTAT HYDROBROMIDE vs TECFIDERA
TAZEMETOSTAT HYDROBROMIDE vs TECHNETIUM TC-99M